3 Things You Need to Watch For in Boston Scientific's Earnings

Medical device maker Boston Scientific's (NYSE: BSX  ) been one of health care's biggest success stories over the past year, with this standout stock climbing 89% over that time. However, its performance hasn't quite lived up to its investors' rewards. Its struggles with revenue as the cardiac rhythm management and stent industries have slowed since the recession, and the company's suffered falling sales in each of the last two years.

Boston Scientific's doing the best it can to turn around that ominous trend. It's managed to slow down revenue losses in its two largest divisions, cardiac rhythm management and interventional cardiology. Meanwhile, up-and-coming businesses such as neuromodulation have stepped up with much-needed revenue growth, although Boston's neurotech sales currently only provide less than a tenth of its overall revenue.

Earnings season's at hand for Boston Scientific, but what should you be watching for when the company reports its quarterly performance on April 29? In the video below, Motley Fool contributor Dan Carroll takes you through the three trends you need to keep an eye on at Boston and whether this company's performance can keep this surging stock on a roll through 2014.

Will Boston Scientific lead the next wave of health-care innovation?
Innovation from forward-thinking companies like Boston Scientific paves the way for huge profits in the health-care sector, and you can't afford to miss out on what could be the next game changer in the medical world. The Economist compares this disruptive invention to the steam engine and the printing press. Business Insider says it's "the next trillion-dollar industry." And the technology behind it is poised to set off one of the most remarkable health-care revolutions in decades. The Motley Fool's exclusive research presentation dives into this technology's true potential and its ability to make life-changing medical solutions never thought possible.  To learn how you can invest in this unbelievable new technology, click here now to see our free report.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2926165, ~/Articles/ArticleHandler.aspx, 9/4/2015 9:15:33 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Dan Carroll

Dan began writing for the Motley Fool in 2012. He is a health care specialist who also follows the defense industry along with tracking the broader U.S. and international markets.

Today's Market

updated Moments ago Sponsored by:
DOW 16,102.38 -272.38 -1.66%
S&P 500 1,921.22 -29.91 -1.53%
NASD 4,683.92 -49.58 -1.05%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/4/2015 4:03 PM
BSX $16.24 Down -0.29 -1.75%
Boston Scientific… CAPS Rating: ***
ABT $43.07 Down -1.07 -2.42%
Abbott Laboratorie… CAPS Rating: *****
MDT $68.98 Down -1.00 -1.43%
Medtronic CAPS Rating: *****
STJ $69.64 Down -0.74 -1.05%
St. Jude Medical,… CAPS Rating: *****